We are live on
!
Find out more
PC
Polar Capital Portfolio holdings
AUM
$13.5B
1-Year Est. Return
55.9%
This Fund
S&P 500
This Quarter
Est. Return
+4.91%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$5.3B
AUM Growth
-$16.8M
(-0.32%)
Cap. Flow
-$266M
Cap. Flow
% of AUM
-5.01%
Top 10 Holdings %
Top 10 Hldgs %
22.18%
Holding
297
New
35
Increased
74
Reduced
86
Closed
35
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$60.5M |
| 2 |
S&P Global
SPGI
|
+$52.3M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$41.3M |
| 4 |
AGN
Allergan plc
AGN
|
+$38.2M |
| 5 |
LVNTA
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
|
+$37.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$98.3M |
| 2 |
Eli Lilly
LLY
|
+$54.1M |
| 3 |
Apple
AAPL
|
+$51.2M |
| 4 |
Fidelity National Information Services
FIS
|
+$42.9M |
| 5 |
Stryker
SYK
|
+$40.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.18% |
| 2 | Financials | 21.66% |
| 3 | Technology | 21.39% |
| 4 | Communication Services | 9.45% |
| 5 | Consumer Discretionary | 5.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
ServiceNow
NOW
$102B
| $11.2M | 0.21% |
842,690
-483,420
| -36% | -$6.72M |
|
127
Lazard
LAZ
$4.37B
| $11.2M | 0.21% |
375,500
-493,099
| -57% | -$17.1M |
|
128
RLI Corp
RLI
$5.68B
| $11.2M | 0.21% |
325,000
| – | – |
|
129
SiriusPoint
SPNT
$2.98B
| $11.1M | 0.21% |
950,000
| – | – |
|
130
Palo Alto Networks
PANW
$264B
| $11M | 0.21% |
540,726
-238,650
| -31% | -$5.53M |
|
131
Teva Pharmaceuticals
TEVA
$35.9B
| $10.9M | 0.21% |
217,567
-645,000
| -75% | -$34.3M |
|
|
LOGM
132
DELISTED
LogMein, Inc.
LOGM
| $10.9M | 0.21% |
171,719
-49,569
| -22% | -$2.86M |
|
|
ELGX
133
DELISTED
Endologix Inc
ELGX
| $10.6M | 0.2% |
84,767
-10,504
| -11% | -$1.21M |
|
134
Pegasystems
PEGA
$4.41B
| $10.5M | 0.2% |
+776,600
| New | +$10.2M |
|
135
Inogen
INGN
$167M
| $9.7M | 0.18% |
193,524
| – | – |
|
136
Align Technology
ALGN
$12B
| $9.67M | 0.18% |
120,000
| – | – |
|
|
SCHW
137
Charles Schwab
SCHW
$177B
| $9.65M | 0.18% |
381,383
-467,780
| -55% | -$13.3M |
|
138
Ralph Lauren
RL
$22.2B
| $9.45M | 0.18% |
105,445
| – | – |
|
|
ULTI
139
DELISTED
Ultimate Software Group Inc
ULTI
| $8.97M | 0.17% |
42,634
+2,092
| +5% | +$415K |
|
140
Wells Fargo
WFC
$261B
| $8.75M | 0.17% |
184,718
-1,500
| -0.8% | -$73.1K |
|
|
CELG
141
DELISTED
Celgene Corp
CELG
| $8.62M | 0.16% |
87,371
-2,778
| -3% | -$287K |
|
|
LLTC
142
DELISTED
Linear Technology Corp
LLTC
| $8.61M | 0.16% |
185,152
+51,500
| +39% | +$2.35M |
|
|
HIMX
143
Himax Technologies
HIMX
$2.2B
| $8.56M | 0.16% |
1,037,351
-85,107
| -8% | -$840K |
|
144
Progressive
PGR
$124B
| $8.38M | 0.16% |
250,000
| – | – |
|
|
NXTM
145
DELISTED
NxStage Medical Inc.
NXTM
| $8.13M | 0.15% |
+375,194
| New | +$6.69M |
|
146
Heritage Insurance Holdings
HRTG
$842M
| $8.08M | 0.15% |
675,000
| – | – |
|
147
SLR Investment Corp
SLRC
$706M
| $7.76M | 0.15% |
407,500
| – | – |
|
148
Workday
WDAY
$33.4B
| $7.76M | 0.15% |
103,965
+55,310
| +114% | +$4.22M |
|
149
Ares Capital
ARCC
$13.5B
| $7.45M | 0.14% |
525,000
| – | – |
|
150
AbbVie
ABBV
$458B
| $7.43M | 0.14% |
120,000
-21,027
| -15% | -$1.28M |
|
Similar funds
ECM
FAAS
WAM
FS
NIMC
TI
VIM
PS
Polar Capital's Q2 2016 Portfolio in Review
As of Q2 2016, Polar Capital held 297 positions worth $5.3B, down 0.32% from $5.32B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Polar Capital withdrew a net $266M in Q2 2016, closing 35 positions and reducing 86 holdings. Its most notable exit was Stryker, an estimated $40.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 23% a quarter earlier, followed by Financials and Technology.
Against the trend, Polar Capital opened a new position in S&P Global worth $52.2M.
- Polar Capital's largest Q2 2016 buy was S&P Global: 487,049 shares worth $52.2M.
- Polar Capital added most to Pfizer in Q2 2016, an estimated $60.5M increase.
- Polar Capital's biggest Q2 2016 reduction was Johnson & Johnson, cutting an estimated $98.3M.
- Polar Capital fully exited Stryker in Q2 2016, selling an estimated $40.2M.
- Polar Capital's ten largest holdings make up 22% of its $5.3B portfolio in Q2 2016.
- Polar Capital opened 35 new positions and closed 35 in Q2 2016.
- Polar Capital's portfolio value fell 0.32% quarter-over-quarter to $5.3B.
Based on Polar Capital's 13F filing for Q2 2016, filed 15 Aug 2016.